NewGenIVF Group Limited (Nasdaq: NIVF) announced it has completed an exchange agreement with an institutional investor, replacing existing convertible notes with a new senior convertible note on amended terms. The transaction closed on August 14, 2026.

The restructuring eliminates a prior mandatory requirement that a significant percentage of proceeds from new capital raises be applied to prepay the notes under a Repurchase and Forbearance Agreement dated June 16, 2026. The new note includes a leak-out framework and other modified terms.

"This exchange represents an important step in improving the terms of our capital structure," said Alfred Siu, Founder, Chairman and CEO of NewGen. "By removing the previous mandatory proceeds sweep and establishing more constructive terms, we enhance our ability to manage future financing activity in a manner that better supports the Company's strategic objectives and long-term growth."

The full agreement will be filed as an exhibit to the company's Report on Form 6-K with the U.S. Securities and Exchange Commission. NewGenIVF said it continues to evaluate additional opportunities to optimize its capital structure.

NewGenIVF is based in Bangkok and operates across real estate development, digital assets, and reproductive health services.